
zzso control of the balance between protein zzso zzso by protein zzso and protein zzso zzso by protein zzso is essential for cellular zzso zzso of this balance leads to zzso states, driving diseases such as cancer, heart disease, and zzso zzso zzso of components of the pathways that control cell growth and cell survival are particularly prevalent in zzso One of the most studied tumor zzso in these pathways is the zzso zzso zzso zzso and zzso zzso deleted on zzso zzso which zzso the zzso second zzso zzso zzso zzso thus preventing zzso of the zzso zzso zzso zzso zzso zzso viral zzso zzso In 2005, the discovery of a family of protein zzso whose members directly zzso and zzso zzso introduced a new negative regulator of the zzso zzso zzso zzso zzso zzso zzso domain zzso repeat protein zzso zzso zzso comprise a novel tumor zzso family whose two members, zzso and zzso are deleted as frequently as zzso in zzso such as those of the zzso zzso is thus a novel therapeutic target to suppress zzso pathways and is a potential candidate zzso to zzso patients for the appropriate targeted zzso This review discusses the role of zzso in terminating zzso signaling and how pharmacological intervention would impact this zzso 

